Cambodia Phar-Med 2018
2018-09-05 - 2018-09-07 | Diamond Island Convention and Exhibition Center, Phnom Penh, Cambodia
This is the biggest trade fair for the medical industry in Cambodia, focused on hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors, providing the perfect platform to discover the latest industry innovations, to network and do business.

Cambodia Lab Expo 2018
2018-09-05 - 2018-09-07 | Diamond Island Convention and Exhibition Center, Phnom Penh, Cambodia
The most definitive event for Laboratory Industry in Cambodia. Gathering the region’s hospital, Diagnostic, Laboratory, Analytical, Biotechnology and Scientific Instruments & Technology sectors in one convenient location and providing the perfect platform to discover the latest industry innovations, to network and do business.

LogiPharma
2018-09-05 - 2018-09-06 | Hilton Penn’s Landing, 201 South Columbus Blvd , Philadelphia, PA, 19106, United States
LogiPharma – Supply Chain. Optimized.
September 5-6, 2018
Hilton Penn’s Landing, Philadelphia, PA

LogiPharma (September 5-6, 2018 Hilton Penn’s Landing, Philadelphia, PA) is a senior-level conference for supply chain VPs and Directors from leading biotechs and pharmaceutical manufacturers. We’re the only end-to-end global supply chain event designed to help you strengthen operations in an informative and interactive setting. Learn how to better serve your customers through complete supply chain visibility and minimize costs in a dynamic healthcare environment at LogiPharma.
To learn more about this event, and to register online, visit http://bit.ly/2GHGsKl

Medical Fair China 2018
2018-09-06 - 2018-09-08 | Suzhou International Expo Center, 688 E. Suzhou Avenue, Suzhou industrial Park, Suzhou, China
MEDICAL FAIR CHINA is a trade fair in the product family MEDICAlliance and takes place in close cooperation with the team of Düsseldorf’s leading global trade fair MEDICA.

Messe Düsseldorf is committed to transferring MEDICA’s successful experience and expertise to China and integrating the latest expert perspectives, trade opportunities and market insights into the exhibition.
Five high caliber events staged at the same time and place will include China Medical Innovation Forum (CMIF), Transformation Medicine and Innovation Service Forum (TM&IS), Device China, China Medical Device Design & Startup Competitions (CMDDSC), FTR4H Talk & Lounge and over 10 sub forums, expecting to cover up to 20,000 square meters.
In attendance will be over 400 local and international innovative medical device R&D institutions and manufacturers, renowned innovation service providers. 5,000 forum participants are expected amongst which are investors, presidents and clinicians, universities and research institutes as well as global dealers and market leaders from across the globe, together with the visitors of Medical Fair China, in total over 15,000 industry peers are estimated.
To learn more about Medical Fair China 2018, and to register online, visit www.medicalfair.cn/en-us

World Drug Safety Congress Europe 2018
2018-09-10 - 2018-09-11 | Mövenpick Hotel, Amsterdam
World Drug Safety Congress Europe was the first strategic pharmacovigilance event to unite a plethora of stakeholders in drug safety, from pharma and biotechs to regulators and patients. The event continues to lead the way in moving the sector forward and has been running for over a decade. It is world renowned for its ability to connect key stakeholders and grow the industry.

The event has grown over the years in tandem with the market. World Drug Safety Congress Europe is the only forum where you can discuss drug safety solutions, meet future clients and begin new partnerships. On the back of our successful European show, we brought the event to the States in 2008 and will hold our 10th Americas meeting in Philadelphia next year.
All our clients return year-on-year to showcase their solutions to our senior level audience. We are constantly revamping our content, formats and topics to stay ahead of market needs which enables us to deliver the best drug safety event in the marketplace today.
New for this year, we will focus on big data management in drug safety and new data sources which will help us to build on the diversity of perspectives and organisations represented. We have welcomed over 1650 senior level drug safety professionals to the event over the years.
To learn more about World Drug Safety Congress, and to register online, visit https://bit.ly/2ruzgMH
Contact
Karina Kusova
E: karina.kusova@terrapinn.com
T: +442070921071

The Microbiome Movement – Skin Health & Dermatology Summit
2018-09-10 - 2018-09-12 | The Sheraton San Diego Hotel & Marina – Bay Tower, 1380 Harbor Island Drive, San Diego, CA, CA 92101, United States
As scientific publications and investment into skin microbiome R&D intensify, there are still fundamental bottlenecks in truly understanding the underlying biology of host-microbiome interactions, standardization of basic research and effective product development.

The Microbiome Movement – Skin Health & Dermatology will unite over 100 KOL’s, senior drug developers, cosmetic product developers & technology experts to harness the skin microbiome and accelerate the discovery, development & commercialization of dermatological therapeutics and the next-generation of cosmetics, founded on clinically validated data.
Join key decision pharma, biotech, cosmetic and consumer health companies to unlock the potential of the skin microbiome through sharing insight and case studies around best practice. Take a look at the event guide now to see the finalized program and meet the speakers: https://bit.ly/2Lmh0NS

Extractables and Leachables China 2018
2018-09-11 - 2018-09-12 | Mercure Beijing Downtown
Following on from the hugely successful and long-running E&L Europe and E&L USA events, Smithers Rapra are now extending the popular conference series into China. The inaugural event will take place in Beijing on 11-12 September 2018.
With extractables and leachables growing in importance in China, understanding the regulatory landscape, testing methods, guidelines and best practices for carrying out E&L studies is extremely important to ensure consumer safety and eliminate risk. That’s why this conference is truly unmissable for anyone in this sector.
As China’s first two-day conference dedicated solely to extractables and leachables, E&L China will equip those currently working within or planning to work within this evolving market with the information they need to succeed. Local stakeholders and renowned experts will come together for two days of training, learning and networking.
Smithers Rapra has been organising the European and North American editions of this conference series for over 10 years, and has a long history of providing E&L testing so you can be sure that this conference will provide you with the most up-to-date and relevant information, as well as a productive and valuable conference experience.
Whatever your level or position, Extractables and Leachables China is the place you need to be this September, so mark your calendar and book your ticket now to avoid missing out!

The 4Bio Summit: USA
2018-09-13 - 2018-09-14 | The Holiday Inn San Francisco – Golden Gateway, USA
Global Engage is pleased to announce the 2018 4BIO Summit comprised of the 4th qPCR and Digital PCR Congress USA and the 3rdMicrofluidics Congress USA. The event will be held on the 13th-14th September 2018 in San Francisco, USA and is part of our successful life science technologies series with a sister event in Europe in December.
The conference will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, expert led case study presentations, panel discussions, and interactive Q&A sessions from a 50 + speaker faculty.
To learn more about this event, and to register online, visit http://www.global-engage.com/event/4bio-usa

The 5th Global Precision Medicine & Biomarkers Leader’s Summit
2018-09-13 - 2018-09-14 | Holiday Inn Munich
EXAMINING GROUNDBREAKING BIOMARKER, COMPANION DIAGNOSTIC, IMMUNO-ONCOLOGY, GENOMIC & BIG DATA AND AI RESEARCH TO FACILITATE THE DEVELOPMENT OF IMPACTFUL PERSONALIZED TREATMENTS FOR PATIENTS
Following the very successful 2017 meeting, Global Engage are beginning work on the 5th Global Precision Medicine & Biomarkers Leaders Summit which will take place on September 13-14, 2018 in Munich, Germany. The 2018 summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.
Attending this Summit will provide you with the opportunity to mix and interact with experts working in all facets of Precision Medicine through the individual, panel and roundtable discussions on offer. It is a Summit not to be missed.

Pharma Serialization Exchange
2018-09-18 - 2018-09-19 | Plaza Frankfurt Congress Hotel, Frankfurt Am Main, Germany
The Pharma Serialization Exchange is the meeting place for the worldwide serialization, IT, trace and trace and supply chain community. The exchange format has been specially curated to enable you to get the latest innovations, advancements, and insight in the most innovative, interactive and inspiring way. Covering all the key topics that are at the heart of serialization, the conference will provide a total and complete insight into the latest developments in the space of pharma serialization.

To learn more about this event, and to register online, visit http://pse.encom-global.com

Pharma Packaging, Automation, Labelling & Yield
2018-09-18 - 2018-09-19 | Plaza Frankfurt Congress Hotel, Frankfurt Am Main, Germany
The Pharma PLAY is the meeting place for the worldwide packaging, labelling and regulatory community. The exchange format has been specially curated to enable you to get the latest innovations, advancements, and insight in the most innovative, interactive and inspiring way. Covering all the key topics that are at the heart of packaging and labelling, the conference will provide a total and complete insight into the latest developments in the space of pharma packaging.

To learn more about this event, and to register online, visit http://pharmaplay.encom-global.com

3rd European Prefilled Syringes Summit
2018-09-19 - 2018-09-20 | Berlin, Germany
After the two successful ACI’s European Prefilled Syringes Summit, we are pleased to announce the next edition which shall take place on the 19th & 20th September in Berlin, Germany.

The event will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation , portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
There are several elements that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and needle stick prevention.
Key Topics Include:

Market Insights –what is happening in the PFS & Devices Market
Regulation of the Manufacture and Control
Technical Advances in mechanisms, application systems. And devices
Improving quality, connectivity, and cost control for combination products
Next generation materials & design of PFS
Balancing biopharmaceutical product portfolio for continual product innovation & Creating a lower-risk product development strategy
Smart devices: their emerging role in auto-injector systems & driving innovation
Shift from glasses pre-filled syringes to plastic prefilled syringes

£240subscriber’s discount available on the registration fee.
To receive the agenda or for the priority registration, please contact
Mohammad Ahsan on +44 (0)20 3141 0606 or email:mahsan@acieu.net

Pharma Packaging, Labelling, Serialization, Track and Trace 2018
2018-09-19 | Kohinoor Continental Hotel, Andheri Kurla Road, Andheri ( E ), Mumbai 400059 – India, Mumbai, India
The Pharma Packaging, Labelling, Serialisation, Track and Trace 2018 conference organized by Virtue Insight will provide a great opportunity for learning and networking. The goal of the conference is to uncover the insights of the most emerging best practices and industry expertise in the field of packaging & labelling in the pharmaceutical sector. This conference attracts packaging, labelling, serialisation, track and trace and artwork experts from across big and small pharma, who come together to share case studies, discuss the current challenges and find solutions.
This year we will be exploring topics, which affect both commercial labelling and packaging teams across small, medium and large pharma. We will have a co-presentation looking at the industries end-toend labelling strategy to ensure companies are inspection ready while harnessing branding as a storytelling tool to remain relevant to your consumers, old and new. Coupled with this we aim to show ways through which the operational challenges of serialization can be overcome and improved to ensure you are meeting compliance standards.
KEY SPEAKERS:

OMPRAKASH S. SADHWANI, Joint Commissioner (Nashik Division), Food and Drugs Administration (M.S.)
AMIT KALE, Associate Vice President – Packaging and Automation, Reliance
TAPAN PATI, Director & Senior Legal Counsel, South Asia, Johnson & Johnson
VISHWANATH MALKAR, President Quality Management, ASolution Pharmaceuticals
CHANDRA SEKHAR, Vice President Quality, Reliance Life Sciences
SAMIR VASAVADA, Associate Director – MS&T and PLM, Abbott
LOKESH SHARMA, Director-Supply Chain, Eisai Pharmaceuticals
SHALIGRAM RANE, Site Quality Head, Biotech Division, Lupin
NARESH TONDARE, Head– India and Nepal Regulatory Affairs, Glenmark Pharmaceuticals
MILIND ANTANI, Partner In-Charge – Pharma LifeSciences, Nishith Desai Associates
ALAP GANDHI, Head, Medical Affairs, Glaxo Smith Kline (GSK)
R.SALUNKHE, Former Assistant commissioner, FDA Maharashtra
RANJIT BARSHIKAR, QbD / CGMP Consulting, Member Editorial Board Journal of Generic Medicines, England
VINEET CHAUDHARY, General Counsel, Wockhardt
VIRENDRA SINGH, Manager Packaging Development, Stelis

KEY THEMES DISCUSSED:

End-to-End optimization: solutions and challenges
Best practice guide to gain advantage on your product packaging and labelling
Efficient serialisation strategies: Business Case, Road map and basic decisions
Discuss your serialization, track and trace, and brand protection programs with peers at this interactive session
Recognize industry best activity solutions to better your labelling analyse activity and distinguish potential errors
Current cost-effective packaging methods and innovations for pharmaceutical packaging
Rethinking Supply Chain Strategy – Securing it
Smart Packaging and Labelling – Warehouse & Logistics – Lessons to learn
Developing an efficient and smart packaging strategy to adapt to new challenges
Developing products and packaging while focusing on patient/consumer needs and demands
Improving consumer experience while researching directions in pharmaceutical packaging
Making packaging to better the patient lives – enhancing revenue by remaining the first choice
Challenges and solutions while temperature controlled packaging
Making sure you are top of the changing labelling landscape by figuring your inspection forwardness strategy
How can companies and government work closely together and its importance?
Global guideline alterations without compromising your present timelines to set up an internal tracking and reporting systems
Setting up best practice to avoid counterfeits getting into your drug supply chain
Global regulatory end-to-end tracking process and its critical functionality
Investigating the wider regulatory surroundings to insure your packaging, labeling, serialisation, track and trace schemes are regulatory compliant and inspection ready
Challenges of implementing the falsified medicines directives in India
Be part of a major networking opportunity

WHO SHOULD ATTEND:
CEO’s, Senior Vice Presidents, Vice Presidents, Senior Executives, Heads, Directors, Managers, Advisors, Strategists and Analysts of:
Pharmaceutical companies, Biotech companies, Artwork, Serialisation, Track and Trace – Solution Providers, Brand Protection, Enforcement, security, Integrity and Management companies, Design Regulatory Affairs, Quality, Product Development Materials Handling/Management, Product Information Operations, Licensing, Marketing and Sales Patient Compliance, Materials, Warehouse, Engineering Lean Production, Procurement, Purchase/Facilities Manufacturing Technology, Supply chain and Logistics, Government, Payers, Insurance companies.
CONFERENCE REGISTERATION:
In order to register you can simply let us know your interests through Email: kavitha@virtueinsight.co.in or Mobile- +91 8270495331 or TEL: +91 44 24762472

Early Bird Discount Price (Till 2nd August 2018) – INR 6,000 + GST(18%) per delegate
Standard Price (3rd August 2018 Onwards) – 1 or 2 delegate – INR 7,000 + GST(18%) per delegate
Group Discounts – 3 or 4 delegates – INR 6,500 + GST(18%) per delegate
Group Discounts – For 5 & above delegates – INR 6,000 + GST(18%) per delegate
Spot Registration on the day of the conference – INR 8,000 + GST(18%) per delegate
Conference Sponsor, Exhibition Stall (Booth) and a paid Speaker slots are also available

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

Deep Learning in Healthcare Summit
2018-09-20 - 2018-09-21 | 155 Bishopsgate, Liverpool Street, London, EC2M 3YD, United Kingdom
The Deep Learning in Healthcare Summit is returning for the 3rd annual event in London! Deep Learning is the most advanced subset of AI and is of interest to many leading players in the AI world. AI is set to revolutionise healthcare and deep learning technology is enhancing all aspects of the industry such as diagnostics, patient care, surgery, health and well being, and pharmaceuticals. The benefits could be life-changing.

Hear from industry leaders, academics, researchers and innovative startups working to advance deep learning technology in Healthcare. Focusing on topics such as medical imaging, speech recognition, diagnostics, pattern recognition and how these are applied within Healthcare. The summit is a great way to discover the latest insights, evaluate your position within the field and how the impacts can affect yourself and your work and network with people working in the field to create opportunities to collaborate and broaden your knowledge.
To learn more about this event, visit https://bit.ly/2M71OZ8

IMPACCT: RWE - Real-World Evidence Conference 2018
2018-09-25 - 2018-09-27 | Hilton Boston/Woburn, 2 Forbes Rd, Woburn, MA, 01801, United States
IMPACCT: RWE is taking place in Boston, MA on September 25-27 2018, and is the only meeting dedicated to supporting drug developers in making real-world evidence-based decisions, from clinical development to commercialization of their products.

Attend this meeting and benefit from:

Case-Study Led Content
We know the value of case-study led discussions. That’s why at the IMPACCT:RWE Summit we’ve tailor-made an agenda that contains over eighteen case studies around how real-world evidence is currently being applied across the drug development continuum to support decision-making in clinical development, drug marketing and commercialization, and how you can define and develop a comprehensive evidence generation plan that supports activities from clinical to commercial. You will have a chance to discuss with peers and learn from thought leaders in the industry such as Lundbeck, Biogen, BMS, Amgen, GSK, Pfizer and more.
Meet and Network with Industry Pioneers
With a room full of senior drug development and commercialization professionals striving to effectively leverage real-world evidence to benefit patients, this summit is your chance to meet like-minded industry peers to shape the future of RWE together.
Pre-Conference Workshop Session
In a highly engaging and interactive discussion, you will learn decision science basics, including implementation examples. The group will also explore opportunities and strategies for RWE to leverage decision science as a vehicle to achieve greater value by informing and helping to change drug development and commercial decision making within your organization.

To learn more about this event, visit http://bit.ly/2OP3kMW

Biosimilars & Biobetters 2018
2018-09-26 - 2018-09-27 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, United Kingdom
SMi presents the 9th Annual Conference on Biosimilars & Biobetters
Forecasting the next wave of biosimilars to ensure optimal market commercialisation
The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK. Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018 will deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.

After over a decade, the biosimilars industry is finally reaching a stage where key stakeholders understand and accept biosimilars. This is reflected in more tolerant legislation and an increased uptake of biosimilars across the globe.
We are now entering a very exciting time, for over the next few years several originator patents are expiring, and we will see the next few waves of biosimilars enter the market. Will the biosimilar be a successful contender and spark a competitive environment or the originator dominate? Have we done enough to convince the payer, prescriber and patient to switch?
Join us to hear experiences of key opinion leaders and evaluate market access, opportunities and commercialisation strategies with industry-thought experts.
This event is CPD accredited.
#SMiBiosimilars
WHO SHOULD ATTEND
Chief Executives, Vice Presidents, Executive Directors, Directors, Heads, Managers and Specialists from the following, but not limited to, sectors should attend:

Biosimilars / Biologics
Biopharmaceuticals
Research and Development
Legal Affairs
Intellectual Property
Regulatory Compliance
Quality affairs and control
Pharmacovigilance, Drug Safety and Risk Management
Business Development
Commercialisation
Marketing and sales

EARLY BIRD-RATES

BOOK BY 30TH APRIL AND SAVE £400
BOOK BY 31ST MAY AND SAVE £200
BOOK BY 29TH JUNE AND SAVE £100

To learn more about this event, and to register online, visit http://www.biosimilars-europe.com/pharmajournalistWL

Immuno-Oncology
2018-09-26 - 2018-09-27 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.
SMi’s Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

At the SMi’s Immuno-Oncology Conference participants will get:
Agenda- Over 15 engaging presentations, case studies, keynote addresses, including:

Targeting immune checkpoints with Humabody VH therapeutics
Recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
Tumour mutation burden and the potential of its use as an indication of treatment choice
Unwanted immunogenicity and functionality testing of immuno-oncology drugs
New techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology

Speakers–Over 15 leading experts in Immuno-Oncology field, including:

James Legg, Vice President R&D, Crescendo Biologics
Andrew Exley, Medical Assessor, MHRA
Harry Smith, Medical Scientist, Gilead Sciences
Grace Macaulay, Global Safety Physician Patient Safety Oncology, MedImmune
David Giljohan, CEO, Exicure
Kandeepan Ganeshalingam, Executive Director, Oncology Therapeutic Area Head, European Clinical Development, MSD
Rochana Wickramasinghe, Director of Oncology Evaluation, AstraZeneca

Workshops – Carefully selected topics for further on-sight training. 2 pre-conference workshops (25 September) to provide in-depth knowledge on specific topics:

Strategic Competitive Intelligence in the Immuno-Oncology space – hosted by LucidQuest Ventures
Could the Microbiome boost Cancer Immuno-Therapy – hosted by ImmuneBiotech and Lund University

Networking – it is at the forefront of SMi events. 5+ hours of pure networking guaranteed. Follow event updates to be in the know about who will be joining the conversation.
To View detailed information about event programme, speaker line-up and workshop agenda visit http://www.immuno-oncology-conference.com/phjWL
Twitter – @SMIpharm & #immunooncologysmi
LinkedIn – SMi Pharma

6th Plant Genomics & Gene Editing Congress: USA
2018-10-01 - 2018-10-02 | The Logan Philadelphia, One Logan Square, Philadelphia, PA, 19103, United States
Attracting scientists working in all areas of plant research, the conference, held on October 1-2 2018, will examine the latest strategies, technologies and research techniques utilizing NGS, ‘omic’ technologies, phenotyping, epigenetics, bioinformatics, regulation and data analysis to further plant research.
To find out more information, please visit our website:
http://www.global-engage.com/event/plant-genomics-usa/
Or email us at info@globalengage.co.uk
Co-Located with the 3rd Partnerships in Biocontrol, Biostimulants, & Microbiome USA

3rd Partnerships in Biocontrol, Biostimulants, & Microbiome: USA
2018-10-01 - 2018-10-02 | Philadelphia, USA, United States
Attracting experts working in all areas of plant science, the conference, held on October 1-2, 2018 in Philadelphia, will examine the latest developments in the technologies and techniques being used for developing biopesticides and biostimulants research, EU regulation, as well as the future of the industry.
URL: http://www.global-engage.com/event/agricultural-biologicals/
Co-Located with the 6th Plant Genomics & Gene Editing Congress: USA

Global Biobanking Congress
2018-10-08 - 2018-10-09 | TBC, London, United Kingdom, United Kingdom
Designed to attract industry leaders and academics, this conference will look at ways to optimize biosample management and consider the future of emerging technologies such as mobile biobanking, digital & cloud-based sample management and automated storage & retrieval systems. Key topics will also include data protection, data sharing, and the importance of ethical and regulatory considerations for maximising clinical impact. The Congress will provide a forum to network, learn, and engage with experts and representatives from pharmaceutical companies, leading institutions, and recognised biobanks worldwide.

Outsourcing in Clinical Trials DACH 2018
2018-10-09 - 2018-10-10 | Radisson Blu, Zurich Airport, Rondellstrasse, 8058 Kloten, CH-8058
We are pleased to announce that the OCT series is extending to Switzerland 2018 to bring innovative and solutions focused content to the DACH biopharmaceutical market. Spinning off from the flagship OCT Europe event this intimate audience of local players allows for focused, lucrative learning and networking on site.

Through in-depth research conducted with local biopharma companies, this event will deliver insight, debate, discussion, presentation and opinion on high priority outsourcing, operations and technology-based themes within the clinical trials space locally.
Key Agenda Highlights 2018
1) Building collaborations with external providers to guarantee the best delivery through innovation. (Gisele Tavares, Procurement – Global Head Alliance Management and Internal Business Partner at Roche)
2) Onstage Interview: Working to foster a reputation in clinical development to partner with large solution providers for trusted timelines and high-quality deliverables – (Dirk Weber, Chief Medical Officer at Cellestia Biotech AG/Aurealis Pharma AG)
3) Considerations in observational research – the importance of long-term partnerships – (Pamela Bacon, Head of Medical Affairs Communications and Operations, Worldwide Markets at Celgene)
Why must you attend?
OCTDACH brings recognised experts specifically in the DACH region to discuss, collaborate and network with a variety of key service providers as well as other biopharmaceuticals from innovative and collaborative ideas to help overcome challenges.
This event will deliver insights, debates, discussions, presentations and opinion on high priority outsourcing, operations and technology-based themes within the clinical trial space locally.
To learn more about this event, and to register online, visit http://bit.ly/OCTDASH2018
Contact:
Phone – +44 (0) 207 936 6521
Email – brijesh.patel@arena-international.com

Cell & Gene Therapy 2018
2018-10-10 - 2018-10-11 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, United Kingdom
SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October.

Cell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing, technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in the field of drug discovery.
This year’s event will be led by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques. The conference will cover all aspects of the subject, including biomedical science principles, molecular basis of disease, current and developing technologies and clinical applications.
The conference will be inviting speakers from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Expect over 16 presentations and case studies focused on the key aspects of GMP, bioprocessing, regulatory frameworks and new therapeutic developments in in the field of cell and gene.
Hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:

Cell Therapy Research
Manufacturing Innovation
Global Medical Affairs
Regulatory Updates
GMP and Quality Control
Cell and Tissue Therapies (CART therapies, stem cells, cord blood, preclinical and clinical developments)
Regenerative Medicine
Advanced Therapy Production
Gene Therapy Development
Clinical Platform Development
Manufacturing
R&D of Cell and Gene Therapies

CHAIR FOR 2018:

Pamela Tranter, Head of Translational Research Group, UCL

KEY SPEAKERS INCLUDE:

Janet Glassford, Senior Quality Assessor (Biologicals), MHRA
Giuseppe Ronzitti, Cell and Gene Therapy Specialist, Genethon
Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
Shailesh Gupta, Senior Scientist, AstraZeneca
Peggy Sotiropoulou, R&D Manager, Research and Development, Celyad
Julie Kerby, Head of Manufacturing Development, Cell and Gene Therapy Catapult
Lior Raviv, Vice President, Development, Pluristem
Diego Aridgo, R&D Rare Disease Unit Head, Chiesi
Mehdi Gasmi, Chief Science and Technology Officer, Adverum Biotech
Emanuela Cuomo, Associate Director, Discovery Sciences, Cellular Biology Team, AstraZeneca
Yen Choo, Founder and Executive Chairman, Plasticell
Ian McKay, Innovation Lead Advanced Therapies, Innovate UK

2018 FEATURED HIGHLIGHTS:

Discuss the challenges of accessing patients with commercial ATMPs
Understand the advantages of a risk-based approach to cell and gene therapy manufacturing
Hear the MHRA’s perspective of UK and EU regulatory affairs regarding ATMPs
Explore the unique applications of the CRISPR/Cas9 system for drug development at AstraZeneca
Gain insight into GMP Manufacture of plasmid DNA at the NHSBT

View the full agenda online: www.cellandgeneconference.com/pj
EARLY-BIRD RATES:

REGISTER BY 31ST MAY AND SAVE £400
REGISTER BY 29TH JUNE AND SAVE £300
REGISTER BY 31ST AUGUST AND SAVE £200

BioNetwork
2018-10-10 - 2018-10-12 | The Ritz-Carlton, Laguna Niguel, One Ritz Carlton Drive, Dana Point, CA, 92629, United States
BioNetwork

October 10 – 12, 2018
The Ritz-Carlton, Laguna Niguel, CA. One, Ritz Carlton Dr, Dana Point, CA 92629

BioNetwork is the essential deal-making event for business development executives in pharmaceutical and biotechnology. You’ll nurture strategic partnerships in our beautiful, intimate venue. Pharma/Big Biotechs – register with code BIO18PHARMA and get 15% off your pass!
To learn more about this event, and to register online, visit bionetwork.wbresearch.com

12th Digital Pharma East
2018-10-16 - 2018-10-18 | Pennsylvania Convention Center, 1101 Arch Street, Philadelphia, PA, 19107, United States
Join more than 800 attendees for the largest event focused exclusively on digital marketing for the life sciences — Digital Pharma East. Our faculty of more than 120 senior-level professionals share their lessons learned and actionable insights to help you leverage innovation to provide an optimal customer experience and improve health outcomes.

To learn more about this event, and to register online, visit digitalpharmaseries.com/east

LogiMed 2018
2018-10-16 - 2018-10-17 | Novotel Amsterdam City, Amsterdam, Netherlands
LogiMed 2018 | Date: 16 – 17 October, 2018 | Venue: Novotel Amsterdam City Amsterdam
LogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark, interact, network and develop professionally.

Download the agenda to find out exactly who is speaking, what the hottest topics are and how LogiMed can benefit you. LogiMed 2018 will bring together 150 Medical Device Supply Chain Professionals and 45 expert speakers over 2 value packed days.
Mixing interactive presentations from Global Heads of Supply Chain with practical, interactive ‘how to’ case studies from proven procurement experts, LogiMed helps Medical Device Manufacturers to transform their supply chain.
As a proud sponsor of the event, we are pleased to offer you an exclusive 15% discount off the full price to attend, using our code: LG18PJ
To learn more about LogiMed 2018, and to register online, visit http://bit.ly/2Mf2l7v

Outsourcing Clinical Trials Pacific Northwest 2018
2018-10-16 - 2018-10-17 | Vancouver
The global OCT series will be returning once again to the Pacific Northwest to celebrate the best in clinical trial management. In 2018 we’ll be visiting Vancouver and will be building on the success of our Seattle 2017 launch.

We’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes, panel debates and roundtables on the biggest issues of the day.
We’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes, panel debates, workshops and roundtables on the biggest issues of the day.
The 2018 agenda highlights include a Keynote session exploring how to underpin and sustain your competitive advantage in the PNW region; an interactive panel discussion comparing experiences with local vs international trials; and a regulatory update to pinpoint what you should be considering when it comes to clinical regulatory aspects.
Join us in Vancouver on October 16th & 17th to discuss, deliberate and debate the latest operational and outsourcing challenges in conducting your clinical trials.
Book your place now to avoid disappointment!
To learn more about this event, and to register online, visit http://www.arena-international.com/octpnw

European Drug Safety Summit 2018
2018-10-17 - 2018-10-18 | London, UK
ACI’s European Drug Safety Summit 2018 will take place in London on 17th & 18th October. The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies. The event will also discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.
Key Topics Include:

Meeting Safety Requirement: Regulator’s Perspective
Building a Pharmacovigilance Strategy
Evolving PV Strategies for Tomorrow
Technological Advancement in Pharmacovigilance
Clinical Data Management
The Role of Big Data and Social Media in PV
Ensure Drug Safety & Risk Minimisation Measures
Latest Development & Innovation Approach for Effective Signal Management
Development of Qualified Personal Responsible for Pharmacovigilance (QPPV)
Pharmacovigilance for Advanced Therapies

Who Will Attend?
Attendees will be drawn primarily from pharmaceutical, biotechnology and contract research organisations and include VPs, Directors and Managers/Scientists working in Drug Safety, Pharmacovigilance, Epidemiology, Clinical Research and Development, Clinical Trial Management, Pharmacology, Regulatory Affairs and Compliance, Strategy and Business Development, Risk Management, QPPV.

Pharma Cold Chain Summit 2018
2018-10-17 - 2018-10-18 | Virtual Conference: Online Access Only
ACI’s Pharma Cold Chain Summit 2018 will be taking place on the 17th & 18th October in London, UK. The two day event will bring together leading experts and stakeholders from across the sector for two days of engaging presentations and interactive discussions. The core challenges and critical issues will be tackled to maintain a robust Cold Chain Management across the global Pharmaceutical Supply Chain.
Join us for a balanced programme of practical, commercial, case-study-based discussions, and to meet industry thought leaders and senior-level decision-makers in an informal environment ideal for sharing ideas and making new contacts.
Agenda: http://bit.ly/2D3csY7

Orphan Drugs and Rare Diseases Conference
2018-10-17 - 2018-10-18 | Holiday Inn Kensington Forum, London, United Kingdom
This year’s SMi’s Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialization, policies, reimbursement, and pricing.
Keep up to date with the industry and to learn from expert speaker panel, bringing you important new case studies and reports on this year’s relevant topics.

HIGHLIGHTS IN 2018:

Discuss the pricing and reimbursement of orphan drugs
Understand the challenges of patient recruitment and patient-centric research
Hear the MHRA’s perspective on benefit-risk assessment in rare diseases
Explore the clinical development of orphan drugs for rare disease
Gain insight into potential synergies between regulators and assessors

SPEAKERS INCLUDE:

Carina Schey, Researcher, University of Groningen
Sheela Upadhyaya, Associate Director, Highly Specialised Technologies, National Institute for Health and Care Excellence (NICE)
Xavier Ortega, Project Manager, Rare Diseases, Minoryx
Nigel Nicholls, Director and Country Manager UK/Ireland, BioMarin Europe Ltd
Yolanda Barbachano, Senior Statistical Assessor, MHRA
Michale Bouskila-Chubb, Head of Business Development, Healx

View detailed agenda, find out who is speaking and book to attend at http://www.orphandrugs.co.uk/phjWL
Twitter – @SMIpharm & #smiorphandrugs
LinkedIn – SMi Pharma
Opt-in – SMi Group value your interest in their events and would like to stay in touch – opt-in via https://www.smi-online.co.uk/opt-in to receive SMi’s updates

Gene Therapy for Rare Disorders Europe Summit
2018-10-22 - 2018-10-24 | Novotel London West, London
2018 is the year gene therapies come into their own. After decades on unfulfilled potential, this space is gaining tangible momentum, particularly in addressing the significant unmet need in a range of rare diseases.

Gene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.
Rather than early stage basic science, this meeting is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Visit the website to see the full agenda, speaker line-up, registration costs and more: https://bit.ly/2KoxFys
Claim a special 10% discount when you quote 9709PJ1 at the checkout.
Contact:
+44 (0)20 3141 8700
info@hansonwade.com
